跳至內容
返回
期刊文章
同儕審查
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma
Chung-Wei Su
,
Wei Teng
,
Eric Yi-Liang Shen
,
Bing-Shen Huang
,
Po-Ting Lin
,
Ming-Mo Hou
,
Tsung-Han Wu
,
Din-Li Tsan
,
Chia-Hsun Hsieh
,
Ching-Ting Wang
, …
顯示15作者詳細資料
The oncologist (Dayton, Ohio), 卷.29(7), 頁碼.e922-e931
01/07/2024
DOI:
https://doi.org/10.1093/oncolo/oyae048
PMID: 38530254
Web of Science ID: WOS:001190796200001
分享
匯出
摘要
檔案與連結 (1)
指標
詳細資料
摘要
Hepatobiliary
This preliminary retrospective study assessed patients with highly advanced hepatocellular carcinoma, exploring the efficacy and safety of concurrent atezolizumab plus bevacizumab with high-dose external beam radiotherapy for these patients.
檔案與連結 (1)
url
https://doi.org/10.1093/oncolo/oyae048
檢視
已出版(紀錄版本)
開放
相關連結
指標
1
檢視次數
30
被引用次數 - Web of Science
See more details
Posted by
10
X users
On
1
Facebook pages
13
readers on Mendeley
詳細資料
題名
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma
研究創作者-僅顯示姓名
Chung-Wei Su
Wei Teng
Eric Yi-Liang Shen
Bing-Shen Huang
Po-Ting Lin
Ming-Mo Hou
Tsung-Han Wu
Din-Li Tsan
Chia-Hsun Hsieh
Ching-Ting Wang
Pei-Mei Chai
Chun-Yen Lin
Shi-Ming Lin
Chen-Chun Lin
Jason Chia-Hsun Hsieh
出版者
Oxford University Press
學術資源類型
期刊文章
出版日期
01/07/2024
出版資訊
The oncologist (Dayton, Ohio), 卷.29(7), 頁碼.e922-e931
語言
英語
顯示其餘
https://doi.org/10.1093/oncolo/oyae048
詳細資料